首页> 外文学位 >A comparison of both water and ethanol extracts prepared from Echinacea purpurea and Echinacea angustifolia on the response to Influenza A/PR/8/34 infection in mice.
【24h】

A comparison of both water and ethanol extracts prepared from Echinacea purpurea and Echinacea angustifolia on the response to Influenza A/PR/8/34 infection in mice.

机译:从紫锥菊和紫锥菊中提取的水和乙醇提取物对小鼠对A / PR / 8/34流感的反应的比较。

获取原文
获取原文并翻译 | 示例

摘要

Influenza is a contagious respiratory disease causing mild to severe illness. The emergence of a new Influenza virus H1N1 pandemic stain in 2009 has increased the risk of another pandemic. Some concern regarding the potential resistance to neuraminidase inhibitors, along with concerns regarding a readily available vaccine to target emerging viruses, and insufficient evidence to recommend use of antibiotics for upper respiratory tract infection (Aroll B et al., 2005), have motivated researchers to look for alternative medicines and other therapies including herbal remedies. Plants species belonging to Genus Echinacea are among the most extensively used herbal remedies for "flu- like" symptoms, and are also known to be used traditionally in North Americans native populations for respiratory illness, wounds, digestive problems, and poisoning (Felter et al., 1983, Hobbs, 1994). Recent research on Echinacea species has been primarily focused on the immune modulatory properties, particularly in preventing and treating respiratory tract infection (Barnes et al., 2005). Several studies using Echinacea extract treatments have reported beneficial effects in preventing and treating respiratory tract infections such as influenza or rhinovirus infections, but the efficacy of Echinacea is debatable due to inconsistent findings. In this dissertation, we report the results of investigation into the effect of different extracts prepared from two commonly used Echinacea species, E. angustifolia and E. purpurea. The in vivo disease model used to test the efficacy of these extracts is a murine model of influenza infection. Both aqueous and ethanol extracts from E. angustifolia and E. purpurea were tested in mice subsequently infected with influenza virus. All extracts tested harbored some level of immune modulatory potential, but showed large variability based on plant species and extraction method used. Aqueous extracts from both species of Echinacea demonstrated greater stimulatory effects on immune responses than did ethanol extracts. The most striking effects were improved survival rate and increase in wide range of cytokine/chemokines in the lungs by water extracts. With respect to a species effect, E. angustifolia extracts tended to have more potent activity than E. purpurea extracts and this held true for both water and ethanol extracts. Modulation of specific cell populations in the lung was also found, but this effect varied by type of extract. In spite of these immunomodulatory changes, there was no reduction in the lung viral load, or any change in weight loss or food intake up to day 8 post-infection.
机译:流感是一种传染性呼吸道疾病,可导致轻度至重度疾病。 2009年出现了新的H1N1流感病毒大流行色斑,这增加了另一场大流行的风险。对神经氨酸酶抑制剂的潜在耐药性的一些担忧,以及针对新兴病毒的现成疫苗的担忧,以及没有足够的证据推荐使用抗生素治疗上呼吸道感染(Aroll B等人,2005年),这促使研究人员开始进行研究。寻找替代药物和其他疗法,包括草药。属于紫锥菊属的植物是用于“流感样”症状的最广泛使用的草药之一,在北美土著居民中,传统上也用于呼吸道疾病,伤口,消化问题和中毒(Felter等(1983年,霍布斯,1994年)。紫锥菊属物种的最新研究主要集中在免疫调节特性上,特别是在预防和治疗呼吸道感染方面(Barnes等,2005)。多项使用紫锥菊提取物治疗的研究已报告了预防和治疗呼吸道感染(例如流感或鼻病毒感染)的有益作用,但由于不一致的发现,紫锥菊的疗效尚有争议。在这篇论文中,我们报告了对两种常用的紫锥菊属植物(E. angustifolia和E. purpurea)制备的不同提取物效果的调查结果。用于测试这些提取物功效的体内疾病模型是流感感染的小鼠模型。在随后感染了流感病毒的小鼠中测试了来自马尾草和紫癜的水提取物和乙醇提取物。测试的所有提取物都具有一定水平的免疫调节潜力,但根据植物种类和所用提取方法显示出较大的变异性。与乙醇提取物相比,两种松果菊属植物的水提物对免疫应答的刺激作用都更大。最引人注目的效果是提高了存活率,并通过水提取物增加了肺中多种细胞因子/趋化因子。就物种效应而言,古铜莲提取物往往比紫杉提取物具有更强的活性,这对于水和乙醇提取物都适用。还发现了肺中特定细胞群的调节,但是这种作用因提取物的类型而异。尽管有这些免疫调节的变化,但直到感染后第8天,肺病毒载量没有减少,体重减轻或食物摄入也没有任何变化。

著录项

  • 作者

    Singh, Navrozedeep.;

  • 作者单位

    Iowa State University.;

  • 授予单位 Iowa State University.;
  • 学科 Health Sciences Immunology.
  • 学位 M.S.
  • 年度 2010
  • 页码 101 p.
  • 总页数 101
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:36:47

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号